Metagenomi Publicly Traded Corporation
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development. The company's metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. Metagenomi forges these naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific, and have a decreased risk of the immune response. Metagenomi's goal is to revolutionize gene editing for the benefit of patients around the world.
The company was founded in 2018 and is headquartered in Emeryville, California.
Investors
Connections from
Total Funding:
456973182
Founded Date:
2018-01-01
Employee Number:
101-250
Last Funding Date:
2023-01-05
Headquarters:
Emeryville,California,United States,North America
Funding Stage:
IPO
Funding Total Value:
456973182
Last Funding Total Usd:
100000000
Last Funding Total Currency:
USD
Last Funding Total Value:
100000000
Founders:
Brian Thomas,Jillian Banfield
Stock Symbol:
MGX
City:
Emeryville
Region:
California
Country:
United States